Home – Research and Development
CureScience was established to develop research centers of excellence through collaborative partnerships with academia as well as the pharmaceutical and biotechnology industries. CureScience™ envisions that this approach will accelerate discovery and commercialization of novel and beneficial diagnostics and therapeutics. We have initiated programs focusing on diagnostics, drug discovery and development, and simplifying patient access to innovative therapies. As a consequence of these efforts, CureScience will address high unmet needs across a broad spectrum of diseases. The prevalence of cancer, neurological, and autoimmune disorders created the necessity of establishing multiple comprehensive Centers of Excellence focused on integrated research and disease management to provide new technologies, diagnostics and therapeutics to combat disease.
These programs are focused on integrated research and disease management, covering preemptive approaches based on multi-faceted “omics”, combined with novel small molecule and biologics drug development. In accordance with our mission to advance efficacious therapeutics rapidly and efficiently, we also will develop programs that focus on repurposing existing drugs. The new era of big data is creating a dynamic real-time patient-centric and patient-specific digital summary. We are establishing protocols to assimilate big data, and parse the information into patient specific, disease specific informatics allowing CureScience™ to rapidly identify patient exigencies and corresponding beneficial therapeutic modalities. In addition, emerging trends in in-silico modeling and drug screening can expedite the deployment of novel and repurposed drugs. This has the potential to improve early detection, accelerate drug discovery and development, identify drug repurposing approaches, and implement precision medicine strategies.
Cancer is not static. Tumors evolve as they respond to treatment or develop resistance.
Beyond supporting individual patients, CureScience works with researchers, clinicians, and biotechnology partners to generate data that can accelerate scientific discovery.
Leptomeningeal disease (LMD) occurs when cancer spreads to the leptomeninges — the delicate membranes that surround the brain and spinal cord. It can arise from many cancers, including breast cancer, lung cancer, melanoma, and gastrointestinal cancers, and is also seen in certain primary brain tumors.
Despite advances in cancer therapy, LMD remains one of the least understood and most difficult complications in oncology. Diagnosis is often delayed, and traditional tools such as imaging and cytology may fail to capture the full extent of disease activity.
CureScience works with physicians and research partners to improve how leptomeningeal disease is detected and studied through advanced molecular approaches.
CureScience brings together multiple layers of biological data to better understand how cancers behave, particularly when they involve the brain and central nervous system.
Genomic sequencing of tumor tissue helps identify mutations, neoantigens, and molecular drivers of disease that may guide targeted therapies or personalized immunotherapies.
Liquid biopsy approaches allow clinicians to detect circulating tumor DNA (ctDNA) and other biomarkers in blood, providing a minimally invasive way to monitor disease progression or treatment response.
See how our research and development process transforms scientific discovery into targeted treatment strategies designed to improve patient outcomes. Learn how CureScience is developing innovative therapies through translational research, drug discovery, and clinical advancement.
Your support helps fuel a mission centered on improving patient care through science and engagement. Donations help advance personalized medicine, support curative therapy development, and strengthen patient engagement networks that inform, empower, and connect communities.
When you support CureScience, you help advance research, strengthen patient engagement, and bring hope closer to real outcomes for patients and families.
Your support helps fuel a mission centered on improving patient care through science and engagement. Donations help advance personalized medicine, support curative therapy development, and strengthen patient engagement networks that inform, empower, and connect communities.
